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Background: Jatropha gossypiifolia L. (Euphorbiaceae) is a medicinal plant largely used in folk medicine. Teas from
the leaves are popularly used as an antithrombotic agent and the branches are frequently employed as a “thick
blood” agent. Considering that the anticoagulant activity associated with antioxidant properties could be beneficial
for various cardiovascular diseases, this study’s aim is the evaluation of anticoagulant and antioxidant activities of
J. gossypiifolia leaves, seeking new therapeutic purposes for this plant.
Methods: The aqueous leaf crude extract (CE) was prepared by decoction and was fractionated by liquid-liquid partition
with solvents of increasing polarity. The phytochemical analysis was performed by thin layer chromatography (TLC) and
by the spectrophotometric quantification of sugars, proteins and phenolic compounds. The anticoagulant activity was
evaluated by prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests. The capacity to act in the
fibrinolytic system (fibrinolytic and fibrinogenolytic activities) was also assessed. The antioxidant activity was evaluated
by total antioxidant capacity, reducing power, copper chelating activity, iron chelating activity, hydroxyl radical
scavenging activity and superoxide radical scavenging assays. The potential toxicity was evaluated using hemolytic assay
and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay on HEK-293 cells.
Results: CE showed significant anticoagulant activity in aPTT test, while no action was observed in PT test, suggesting a
preferential action toward the intrinsic and/or common pathway of coagulation. No effect was observed in the
fibrinolytic system. Using the aPTT test, it was observed that the residual aqueous (RA) fraction was the most active,
being two times more active than CE. RA presented very significant antioxidant activity in all models tested comparable
to or even higher than CE. Regarding the safety, CE and RA did not produce significant cytotoxicity in both tests
employed. Phytochemical analysis revealed the presence of alkaloids, flavonoids, proteins, tannins, steroids and/or
terpenoids and sugars.
Conclusions: CE and RA possessed significant anticoagulant and antioxidant activity and absence of cytotoxic effect
in vitro, thus showing the potential of the plant, especially RA fraction, as a new source of bioactive molecules for
therapeutic purposes, with particular emphasis on the treatment of cardiovascular diseases.
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The use of plants with medicinal purposes for the
prevention and/or treatment of diseases is one of the
most ancient forms of primary health care [1,2]. Plants
produce several secondary metabolites that present many
important biological activities. Anticoagulant and antioxi-
dant activities could be highlighted amongst these.
Anticoagulant drugs are needed for the short-term
treatment of arterial and venous thrombotic disorders
and for the long-term prevention of recurrences [3].
Although heparin has been the mainstay of anticoagulant
treatment for acute thrombotic disorders for decades, this
drug presents some limitations related to its clinical appli-
cation, such as inefficacy in antithrombin deficient patients,
bleeding complications, potential for the development of
heparin-induced thrombocytopenia, immunosuppression
and osteoporotic effect with long-term application as side
effects [3,4]. So, the search for new substances with anti-
coagulant and antithrombotic activities is relevant [4]. Me-
dicinal plants have historically been the first source of
anticoagulant and antithrombotic molecules [5].
Reactive oxygen species (ROS) are free radicals naturally
produced in the cells and are involved in many cellular
biochemical activities such as signal transduction, gene
transcription and regulation of soluble guanylate cyclase
activity [6,7]. However, overproduction of free radicals or
failure in endogenous antioxidant mechanisms can cause
oxidative damage to biomolecules (lipids, proteins and
DNA), eventually leading to many chronic diseases, such
as atherosclerosis, cardiovascular diseases, cancer, diabetes,
rheumatoid arthritis, post-ischemic perfusion injury,
myocardial infarction, chronic inflammation, stroke,
septic shock, aging and other degenerative diseases in
humans [6,7]. Antioxidants are important substances that
have the ability to protect the organism from the damage
caused by the oxidative stress. Due to this ability, there is a
special interest in the presence of natural antioxidants in
medicinal plants that may help the organism to maintain
the normal balance of ROS [7,8]. Plants are frequently re-
ported as a good source of antioxidant components, such
as phenolic compounds [9].
Atherosclerosis is a vascular disease characterized by the
accumulation of fatty substances, cholesterol, cellular waste
products, calcium and other substances in the arterial wall,
and involves an inflammatory response to the local low-
density lipoprotein (LDL) [9,10]. The oxidation of LDL is a
well-described phenomenon in atherosclerosis, and ROS
are involved in the pathophysiology of this disease [6].
Among the injuries that may occur during atherosclerosis
progression, the most severe consequence is the promotion
of thrombous formation, generated by the activation of
platelet aggregation and blood coagulation [11]. Thus, com-
pounds with anticoagulant and antioxidant can be used in
the actual medicine for treatment of atherosclerosis.Jatropha gossypiifolia L. is a medicinal plant belonging to
the Euphorbiaceae family, popularly known in Brazil as
“pinhão-roxo” or known worldwide as “bellyache-bush”.
This species is widely distributed in countries of tropical,
subtropical and dry tropical weather and tropical semi-arid
regions of Africa and Americas [12]. Several human and
veterinary uses in traditional medicine are described for
different parts (leaves, stems, roots, seeds and latex). Prep-
arations based on this plant, such as infusion, decoction
and maceration, by oral or topical routes, are frequently
used. The most frequent reports relate to its antihyperten-
sive, anti-inflammatory, antiophidic, analgesic, antipyretic,
antimicrobial, healing, haemostatic, anti-anemic and anti-
diabetic applications, among other examples [13-15]. An
important feature of J. gossypiifolia species is that, due to
its important potential medicinal applications, it is in-
cluded in the National List of Medicinal Plants of Interest
to Brazilian Public Health System (Relação Nacional de
Plantas Medicinais de Interesse ao Sistema Único de Saúde
Brasileiro – RENISUS), which is a report published by the
Brazilian Health Ministry that includes 71 species of medi-
cinal plants that have the potential to generate pharma-
ceutical products of interest to public health [16].
Regarding the chemical compounds ascribed to this spe-
cies, alkaloids, coumarins, flavonoids, lignoids, phenols,
saponnins, steroids, tannins and terpenoids were already
detected in different extracts from different parts of this
plant [17]. Among the main activities already studied for
this species (including many kinds of extracts from differ-
ent parts of the plant), the antihypertensive, antineoplasic,
antimicrobial, antiophidic and anti-inflammatory activ-
ities mainly stand out, supporting some of its popular
uses [15,18,19].
The present study was carried out aiming to evaluate the
anticoagulant and antioxidant activities of the aqueous leaf
extract of J. gossypiifolia. Using a bioguided fractionation,
the main fraction responsible for the anticoagulant activity
was identified (residual aqueous fraction). This fraction
also possessed significant antioxidant activity in vitro and
absence of cytotoxic effect in vitro, thus showing the po-
tential of the plant and, more specifically, of this fraction
as a new source of bioactive molecules for therapeutic
purposes, with particular emphasis on the treatment of
cardiovascular diseases such as atherosclerosis, since
anticoagulants and antioxidants are used in the treat-
ment of these disorders.
Methods
Chemicals and reagents
Luteolin, orientin, isoorientin, vitexin, isovitexin, D-glicose,
gallic acid, Cremophor® EL (polyoxyl 35 castor oil),
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide
(MTT), Bothrops jararaca snake venom, bovine fibrino-
gen, bovine serum albumin, ascorbic acid, pyrocatechol
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(St. Louis, MO, USA). All reagents of sodium dodecilsu-
phate polyacrylamide gel electrophoresis were purchased
from GE Healthcare (Piscataway, NJ, USA). All reagents
used for cell culture procedures were purchased from Cul-
tilab (Campinas, SP, Brazil). All other reagents and solvents
used were of analytical grade. The water used was purified
by reverse osmosis.
Preparation of pool of plasma and red blood cell (RBC)
suspension
After written informed consent has been obtained, blood
from adult healthy volunteers free from medication for at
least two weeks and fasted for at least 8 h was taken by
venipuncture and collected into 0.105 M sodium citrate
(9:1 v/v, blood: anticoagulant) and K3EDTA (1,5 mg EDTA:
1 mL blood) tubes (BD Vacutainer®, Franklin Lakes, NJ,
USA). The human plasma pool was prepared from the su-
pernatants obtained after centrifugation at 800 g for
10 min at room temperature of the citrated blood. The
plasma was used up to two weeks after being obtained. For
red blood cell (RBC) suspension preparation, blood col-
lected with EDTA was centrifuged at 560 g for 10 min at
room temperature and the red blood cell pellet was subse-
quently rinsed three times with PBS. A 20% (v/v) RBC sus-
pension was obtained by dilution with PBS. The RBC was
used immediately after preparation. The procedures for
human blood collection were approved by the Ethics Com-
mittee in Human Research from Federal University of Rio
Grande do Norte (protocol no. 092/09).
Plant material
Leaves of Jatropha gossypiifolia L. (Euphorbiaceae) were
collected in Carnaubais, municipality of Rio Grande do
Norte State, Brazil, at coordinates 36.80°W 5.27°S, in
April 2012. The botanical identification of the material
was performed by Msc. Alan de Araújo Roque and a
voucher specimen was deposited at the Herbarium from
the Centro de Biociências of Universidade Federal do Rio
Grande do Norte, Brazil (UFRN 12561). The collection of
the plant material was conducted under authorization
of Brazilian Authorization and Biodiversity Information
System (SISBIO) (process number 35017) and Brazilian
Access Authorization and Dispatch Component of
Genetic Patrimony (CGEN) (Process 010844/2013-9).
The leaves were dried at room temperature for about
18 days, triturated with an industrial blender and
stored in hermetically sealed bottles away from light
and humidity until use for extract preparation.
Extract preparation
Dried leaves were submitted to decoction (1:10 w/v, plant:
solvent) for 15 min at a temperature of around 100°C to
obtain the aqueous leaf extract of J. gossypiifolia, namedcrude extract (CE). CE, obtained after vacuum filtration,
was freeze-dried and one part of it was dissolved in PBS at
adequate concentrations for the biological assays.Crude extract (CE) fractionation
CE was fractionated by liquid-liquid partition with sol-
vents of crescent polarity in order to obtain the dichlo-
romethane (CH2Cl2), ethyl acetate (AcOEt), n-buthanol
(BuOH) and residual aqueous (RA) fractions. The frac-
tions were dried and one part of them was dissolved in
PBS or in Cremophor® 5% solution in PBS (according to
fraction solubility), at adequate concentrations for the
biological assays.Phytochemical analysis
For phytochemical characterization of CE and fractions,
they were submitted to thin layer chromatography (TLC)
analysis and had the content of sugar, protein and phenolic
compounds determined spectrophotometrically.Thin Layer Chromatography (TLC)
CE and fractions were analyzed by TLC using aluminium
pre-coated sheets with silica gel F254 (Merck®, Darmstadt,
Germany) as adsorbent. Three mobile phases were
employed: (1) ethyl acetate: formic acid: water (8:1:1 v/v/v),
(2) toluene: ethyl acetate: formic acid (5:5:0.5 v/v/v) and (3)
n-butanol: acetic acid: water (3:1:1 v/v/v). The chromato-
grams were analyzed under 254 and 365 nm UV light and
different spray reagents were used according to the metab-
olite investigated (sulfuric vanillin + heating, natural prod-
uct reagent + UV 365 nm, ferric chloride, Dragendorff
reagent and ninhindrin + heating). The retention factors
(Rf), color and behavior of the spots were recorded for fur-
ther comparison with chromatographic profiles of refer-
ence substances from the literature in the area [20].
Standard samples of flavonoids were employed for co-TLC
analysis.Total content of sugars, proteins and phenolic compounds
Total sugar was estimated by Dubois method using D-
glicose as standard [21]. Phenolic compounds were de-
termined by Folin-Ciocalteu’s method using gallic acid
as standard [22]. The Bradford method was used for
protein quantification using bovine serum albumin
(BSA) as standard [23].Coagulation and fibrinolysis assays
The action of CE and fractions on haemostatic system
was assessed by the evaluation of its anticoagulant activ-
ity in prothrombin time (PT) and activated partial
thromboplastin time (aPTT) tests, as well as by its cap-
acity to act in fibrinolytic system.
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The action in extrinsic pathway was evaluated by PT
test, as previously described in literature, with a few
modifications [24]. The test was carried out using com-
mercial reagent kits (CLOT Bios Diagnostica, São Paulo,
SP, Brazil). Plasma (90 μL) was mixed with 10 μL of
samples (0.1 – 2 μg/μL) and incubated at 37°C for 5 min
at 37°C. Then, 200 μL of PT assay reagent (rabbit brain
extract and calcium chloride) pre-warmed at 37°C for
10 min was added and the clotting time was recorded by
a digital coagulometer (“Laser Sensor” Clotimer, CLOT,
São Paulo, SP, Brazil). Plasma alone (only with vehicle)
was used as control (absence of anticoagulant activity).
Heparin (1 IU/mL) (Cristalia®, Itapira, SP, Brazil) was
used as positive control.
Activated partial thromboplastin time (aPPT) test
The action in intrinsic and common pathways was eval-
uated by aPTT test, as previously described in literature,
with a few modifications [24]. The test was carried out
using commercial reagent kits (CLOT Bios Diagnostica,
São Paulo, SP, Brazil). Plasma (90 μL) was mixed with
10 μL of samples (0.1 – 2 μg/μL) and incubated at 37°C
for 5 min at 37°C, before the addition of pre-warmed
aPTT reagent (rabbit brain extract and ellagic acid) and
incubation at 37°C for 2 min. Pre-warmed (37°C)
25 mM calcium chloride was then added and the clot-
ting time recorded by a digital coagulometer (“Laser
Sensor” Clotimer, CLOT, São Paulo, SP, Brazil). Plasma
alone (only with vehicle) was used as control (absence of
anticoagulant activity). Heparin (1 IU/mL) (Cristalia®,
Itapira, SP, Brazil) was used as positive control.
Fibrinolytic activity
The fibrinolytic activity was determined as previously de-
scribed in literature, with a few modifications [25,26]. First,
100 μL of citrated human plasma was mixed with equal
volume of 100 mM CaCl2 and incubated at 37°C for
120 min for fibrin clot formation. The plasma fibrin clot
was washed 5 times with PBS and then incubated with dif-
ferent concentrations of samples (0.1 – 2 μg/μL) at 37°C
for 120 min. 100 μL of 0.0625 M Tris-HCl pH 6.8 contain-
ing 10% v/v glycerol, 10% v/v β-mercaptoethanol, 2% w/v
SDS and 0.05% w/v bromophenol blue was added,
followed by boiling for 5 min. The samples were centri-
fuged at 800 g for 10 min and the supernatant was then
analyzed by 7.5% SDS-PAGE [27]. Plasma fibrin clot alone
was used as control, for visualization of the intact fibrin
profile. B. jararaca venom was used as positive control for
fibrinolytic activity [28].
Fibrinogenolytic activity
The fibrinogenolytic activity was determined as previ-
ously described in literature, with a few modifications[29]. Different concentrations of samples (0.1 – 2 μg/μL)
were mixed with 50 μg of fibrinogen and then incubated
for 180 min at 37°C. 1.5 M Tris-HCl pH 8.8 containing
10% v/v glycerol, 10% v/v β-mercaptoethanol, 2% w/v
SDS and 0.05% w/v bromophenol blue was added,
followed by boiling for 5 min. The samples were then
analyzed by 12% SDS-PAGE [27]. Fibrinogen alone was
used as control, for visualization of the intact fibrinogen
profile. B. jararaca venom was used as positive control
for fibrinogenolytic activity [28].
Antioxidant activity
The antioxidant activity was evaluated by six in vitro
models: total antioxidant capacity, reducing power, cop-
per chelating activity, iron chelating activity, hydroxyl
radical scavenging activity and superoxide radical scav-
enging activity.
Total antioxidant capacity
The assay for total antioxidant capacity was performed
using the phosphomolybdenum complex formation
method [30]. Tubes containing 100 μg of samples and
the reagent solution (0.6 M sulfuric acid, 28 mM sodium
phosphate and 4 mM ammonium molybdate) were incu-
bated at 95°C for 90 min. Then, the mixture was cooled
at room temperature and the absorbance measured at
695 nm against a blank. The total antioxidant activity
was interpolated using a standard curve with known
concentrations of ascorbic acid and expressed as milli-
gram of ascorbic acid equivalent per gram of extract
(AAE).
Reducing power
The reducing power was quantified as described previ-
ously, with a few modifications [31]. Samples (0.1 –
2 μg/μL) were added to the reaction mixture (0.2 M
phosphate buffer pH 6.6 containing 1% w/v ferricyanide
potassium) and incubated at 50°C for 20 min. The reac-
tion was stopped by adding 10% w/v trichloroacetic acid
solution. Then, the solution was mixed with water and
0.1% w/v ferric chloride. The absorbances were read at
700 nm. The result was expressed as the percentage of
the activity shown by 0.2 μg/μL of ascorbic acid.
Copper chelating activity
The ability to chelate copper ions was assessed using the
pyrocatechol violet method [32]. 30 μL of samples (0.1 –
2 μg/μL) were mixed with 200 μL of 50 mM acetate buf-
fer pH 6.0, 6 μL of 4 mM pyrocatechol violet and
100 μL of 50 μg/μL copper II sulfate pentahydrate. The
absorbances were read at 632 nm in a microplate reader
(Epoch-Biotek®, Winooski, VT, USA). The chelating activ-
ity was expressed as the chelation percentage in relation to
a blank (absence of sample). The IC50 (concentration that
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EDTA was used as positive control.
Iron chelating activity
The ability to chelate iron ions was assessed as previ-
ously described in literature, with a few modifications
[31]. Samples (0.1 – 2 μg/μL) were added to the reaction
mixture containing 2 mM ferrous chloride and 5 mM
ferrozine. The mixture was stirred and incubated for
10 min at room temperature. The absorbance was mea-
sured at 562 nm. The chelating activity was expressed as
the chelation percentage in relation to a blank (absence
of sample). The IC50 (concentration that produces 50%
of iron ion chelation) was calculated. EDTA was used as
positive control.
Hydroxyl radical scavenging activity assay
The scavenging activity against hydroxyl radical was mea-
sured based on Fenton’s reaction, as previously described
in the literature, with a few modifications [33]. Hydroxyl
radicals were generated using 150 mM sodium phosphate
buffer pH 7.4 containing 10 mM ferrous sulphate, 10 mM
EDTA, 2 mM sodium salicylate and 30% hydrogen perox-
ide with different concentrations of sample (0.1 – 2 μg/
μL). In control tubes, sodium phosphate buffer replaced
hydrogen peroxide. The solutions were incubated at 37°C
for 60 min, and the presence of hydroxyl radicals was de-
tected by monitoring the absorbance at 510 nm. The scav-
enging activity was expressed as inhibition percentage
(scavenging percentage). The IC50 (concentration that pro-
duces 50% of hydroxyl radical scavenging) was calculated.
Gallic acid was used as positive control.
Superoxide radical scavenging activity assay
The assay was based on the capacity of the samples to
inhibit the photochemical reduction of nitroblue tetrazo-
lium (NBT) in the riboflavin-light-NBT system, as previ-
ously described, with a few modifications [34]. The
reaction mixture (50 mM phosphate butter pH 7.8,
13 mM methionine, 2 mM riboflavin, 100 mM EDTA
and 75 mM NBT) and samples at different concentra-
tions were mixed. After 10 min under illumination with
a fluorescent lamp, the production of blue formazan was
monitored at 560 nm. Tubes containing only the reaction
mixture were maintained in the dark and served as control
to reaction. The scavenging activity was expressed as in-
hibition percentage (scavenging percentage). The IC50
(concentration that produce 50% of superoxide radical
scavenging) was calculated. Gallic acid was used as positive
control.
Cytotoxic activity
As a preliminary study to evaluate the potential toxicity
of the plant, in vitro cytotoxicity studies were performedin red blood cell suspension (hemolytic activity) and in
human embryonic kidney 293 (HEK-293) cells.
Hemolytic assay
The hemolytic assay was performed as previously de-
scribed in literature, with a few modifications [35].
Briefly, 5 μL of 20% (v/v) red blood cell (RBC) suspen-
sion were incubated at 37°C for 60 min with 500 μL of
samples at different concentrations (0.1 – 2 μg/μL). The
mixtures were then centrifuged at room temperature for
2 min at 8,600 g and the absorbance of the supernatant
was measured at 540 nm with a microplate spectropho-
tometer (Epoch-Biotek®, Winooski, VT, USA). Water
was used as positive control (100% RBC lysis) and PBS
as negative control (absence of RBC lysis). The values of
treated cells were calculated as a percentage of the posi-
tive control.
In vitro cytotoxicity against human embryonic kidney cells
(HEK-293)
Human embryonic kidney 293 cells (HEK-293) (ATCC®
CRL-1573) were cultured under standard conditions in
DMEM (Dulbecco’s modified Eagle’s medium) supple-
mented with fetal bovine serum (FBS) at a final concen-
tration of 10%. Cells were maintained in cell culture
flasks at 37°C in a humidified atmosphere containing 5%
CO2 and were collected by treatment with trypsin. Cells
(1 × 104 cells per well) were seeded in medium supple-
mented with FBS (10%) and cultured for 24 h in 96-well
microplates to promote adhesion. The following day, the
medium was removed and replaced with fresh medium
free of FBS. Serum deprivation was used for synchroniz-
ing cell cycle. The next day, the medium was replaced
with fresh medium with FBS (10%) containing serial di-
lutions of the samples (3.9 – 1000 μg/mL) previously
sterilized in a 0.45 μm membrane. The negative control
was exposed to the standard medium supplemented with
FBS (10%) without sample. After 24 h, the MTT assay
was performed as a marker of cell viability, as previously
described in literature [36]. Briefly, medium containing
extract was replaced with medium containing 1 μg/μL of
MTT and incubated for 4 h at 37°C. After incubation,
the supernatant was removed and the purple formazan
crystal formed was solubilized in ethanol, stirred for
15 min and the absorbance was measured at 570 nm in a
microplate reader (Epoch-Biotek®, Winooski, VT, USA).
The absorbance of the negative control (no sample) was
considered as 100% cell viability and the values of treated
cells were calculated as a percentage of the negative
control.
Statistical analysis
The results were expressed as mean ± SEM with n = 3.
One-way ANOVA with Tukey’s post test or Student’s t-
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GraphPad Prism version 5.00 for Windows, GraphPad
Software, San Diego California USA. p values less than
0.05 were considered significant.
Results and discussion
Antithrombotic drugs are pivotal in the prevention and/
or treatment of thrombotic disorders. Secondary metab-
olites from vegetal origin are a potential source of anti-
coagulant drugs [5]. Its popular use as well as some
interesting studies in literature prompted us to evaluate
the anticoagulant activity of J. gossypiifolia.
Teas obtained by decoction of the leaves of J. gossypii-
folia are popularly used as an antithrombotic agent [37]
and the branches are frequently employed as a “thick
blood” agent, a popular claim related to antiplatelet ac-
tion [38]. Although there is no study in literature about
the possible anticoagulant activity of this plant, a previ-
ous study showed the potentiality of the juice extracted
from the fresh leaves of J. gossypiifolia as an anticoagu-
lant for haematological analyses, with an efficiency com-
parable to conventional laboratory anticoagulants [39].
Therefore, with the aim of therapeutic purposes, the
in vitro anticoagulant action of the aqueous leaf extract
of J. gossypiifolia was investigated in the present study.
The anticoagulant activity of the crude extract of J.
gossypiifolia (CE) was evaluated by the prothrombin time
(PT) and activated partial thromboplastin time (aPTT)
assays, using normal citrated human plasma. As can be
observed in Figure 1, CE was able to prolong the clottingFigure 1 Anticoagulant activity of crude extract (CE) and
fractions from Jatropha gossypiifolia on aPTT test. CE: crude
extract. CH2Cl2: dichloromethane fraction. AcOEt: ethyl acetate
fraction. BuOH: n-butanol fraction. RA: residual aqueous fraction.
Values expressed as mean ± SEM with n = 3. CE, AcOEt, BuOH and
RA, in all concentrations tested, presented p < 0.05 when compared
to control (absence of sample) by Tukey’s test (ANOVA).time in aPTT test by up to 3 times, demonstrating its
anticoagulant activity. In PT test, no prolongation of the
clotting time was observed (results not shown). The pro-
longation of aPTT indicates the inhibition of the intrinsic
and/or common pathway of coagulation, whereas no pro-
longation of PT demonstrates no inhibition of the extrinsic
pathway [24]. So, the present results suggest that CE in-
hibits preferentially intrinsic and/or common pathways of
coagulation. Heparin was used as positive control and as
expected presented significant anticoagulant activity, with
PT higher than 60 s (negative control: 16.27 ± 0.32 s) and
aPTT higher than 240 s (negative control: 35.07 ± 0.03 s).
In order to identify the constituents of CE responsible
for the anticoagulant activity presented, a phytochemical
screening by thin layer chromatography (TLC) was per-
formed. But first, the CE was fractionated by liquid-liquid
partition to obtain fractions with different polarities and
thus facilitate the chromatographic analysis of the com-
pounds. The yields are presented in Table 1. As can be ob-
served in the Table 1, the fractions with higher yield are
the more polar ones (BuOH and RA fractions), thus sug-
gesting that in CE there is a predomination of polar over
apolar compounds.
The chromatographic analysis of CE and fractions of J.
gossypiifolia with specific spray reagents indicated the
presence of alkaloids, terpenes and/or steroids, phenolic
compounds, flavonoids, tannins and amines.
According to TLCs performed and by comparison
with the literature, CH2Cl2 fraction presented green-
fluorescent bands when revealed with natural product
reagent under UV 365 nm, suggesting the presence of
flavonoids, as well brownish bands with Dragendorff ’s
reagent, suggesting the presence of alkaloids.
In the AcOEt fraction, treatment with ferric chlor-
ide revealed several dark bands suggestive of phenolic
compounds. The presence of tannins can also be sug-
gested, detectable as pink bands by sulfuric vanillin
under heating that revealed as black bands with ferric





Yield (%), in relation to
dried leaves* crude extract**
CE 13.57 100
CH2Cl2 fraction 0.53 3.87
AcOEt fraction 0.43 3.19
BuOH fraction 3.67 27.07
RA fraction 3.92 28.85
CE: crude extract. CH2Cl2: dichloromethane fraction. AcOEt: ethyl acetate
fraction. BuOH: n-butanol fraction. RA: residual aqueous fraction. *yield
calculated based on initial amount of dried leaves used in the preparation of
the crude extract (50 g). **yield calculated based on amount of equivalent
dried CE use for fractionation (6.79 g).
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ethyl acetate: formic acid: water (8:1:1, v/v/v) and revela-
tion with natural product reagent under UV 365 nm, the
presence of some bands with Rf (retention factor) and col-
oration characteristics of the following flavonoids could be
observed in AcOEt fraction: isoorientin (Rf = 0.4, dark
yellow-orange band), isovitexin (Rf = 0.45, green fluores-
cent band), orientin (Rf = 0.52, yellow band) and vitexin
(Rf = 0.62, green fluorescent band). A band with Rf and col-
oration characteristics of the flavonoid luteolin (Rf = 0.54,
yellow fluorescent band) was also observed by co-TLC in
this fraction, employing the mobile phase toluene: ethyl
acetate: formic acid (5:5:0.5, v/v/v) and revelation with nat-
ural product reagent under UV 365 nm.
The BuOH fraction TLC analysis revealed only flavo-
noids, since all bands revealed with vanillin were re-
vealed with natural product reagent. By co-TLC, some
bands were observed that were similar to those detected
in AcOEt fraction: isoorientin, orientin and vitexin.
In RA fraction it was not possible to visualize the pres-
ence of clear bands when the plate was developed with
the spray reagents, except for the presence of a brownish
zone at the point of application in the TLC plate re-
vealed with sulfuric vanillin, which could indicate the
presence of sugars; a black zone at the point of applica-
tion when revealed with ferric chloride, which is indica-
tive of phenolic compounds; and the presence of a
purple zone with ninhidrin, which could indicate the
presence of amino acids, peptides and/or proteins. In
view of the possible presence of sugars, phenolic com-
pounds and proteins, as well as the lack of more con-
crete clues about the compounds present in RA fraction,
the content of these compounds was determined in this
fraction and in CE, as shown in Table 2.
Based on these dosages, the presence of phenolic com-
pounds and sugars could be confirmed. In addition, it
could be visualized that proteins represent only a low
percentage of the crude extract composition.
With the exception of luteolin, the other flavonoids have
already been identified in the leaves of J. gossypiifolia
[40,41]. For the genus Jatropha, luteolin was described
previously only in the species Jatropha unicostata [42].
Additionally, to the best of our knowledge, there are no
phytochemical studies regarding the use of water as solvent
for the extraction of J. gossypiifolia constituents. This is im-
portant to be noted since popular use occurs moreTable 2 Content of sugars, phenolic compounds and
proteins of crude extract (CE) and residual aqueous
fraction (RA) from Jatropha gossypiifolia
Sample Sugars (%) Phenolic compounds (%) Proteins (%)
CE 20.0 ± 0.3 18.7 ± 1.5 2.4 ± 0.4
RA fraction 15.6 ± 0.6 15.2 ± 1.0 3.7 ± 0.3
Values expressed as mean ± SEM with n = 3.frequently with infusions or decoctions, and thus, little is
known about the constitution of this type of extract. Fur-
thermore, more commonly, the studies with J. gossypiifolia
presented in the literature use solvents or mixtures of
solvents with non polar characteristics, which could
contribute to further characterization mainly of non
polar compounds such as terpenoids and lignoids. Polar
compounds such as flavonoids, tannins and sugars are
poorly described in the species so far [12,17].
Giving continuity to the assessment of the anticoagulant
activity of J. gossypiifolia, the four fractions obtained from
CE were evaluated by the aPTT and PT test. In relation to
PT, no alteration was observed with any of the fractions
(results not shown). On the other hand, in the aPTT test,
interesting results were obtained, as can be observed in
Figure 1. Once again, an action preferentially towards the
intrinsic and/or common pathway of coagulation could be
suggested for aqueous leaf extract of J. gossypiifolia, since
any of the fractions presented prolongation of PT, but
some of them prolonged the aPTT. These active fractions
in aPTT were the most polar ones: BuOH and RA. The
AcOEt presented statistically significant prolongation of
aPTT (p < 0.05), however, this anticoagulant activity was
not significant from the biological point of view. The
BuOH fraction presented anticoagulant activity, but this
was weaker than the CE. The RA fraction was the most ac-
tive, prolonging the aPTT by up to 6 times, being 2 times
more active than CE. Based on this, it is possible to con-
clude that this fraction contains the main compounds re-
sponsible for the anticoagulant action observed in the
aqueous leaf extract of J. gossypiifolia.
In addition to anticoagulant activity, CE and RA were
also tested in relation to their capacity to hydrolyze fi-
brin and fibrinogen, in view of investigating its potential-
ity as a thrombolytic agent. However, in both tests
employed, no effect was observed (results not shown).
These are interesting results since it show that the
anticoagulant activity observed may be due an inhibitory
action upon clotting factors, and not only to a simple
degradation (proteolytic action) of the proteins involved
in the coagulation cascade. Additionally, the fact that
only aPTT was prolonged shows that the inhibitory ef-
fect is not due to a simple chelation of calcium ions,
since if it was true, the PT should be prolonged too,
what was not observed. One possible hypothesis for the
anticoagulant action observed is the presence of protease
inhibitors in CE, especially serine proteases inhibitors,
since the coagulation is constituted, basically, of a cascade
of proteolytic enzymes. In fact, Félix-Silva et al. [18]
showed that the aqueous leaf extract of J. gossypiifolia was
able to inhibit several enzymatic and biological activities
induced by Bothrops jararaca snake venom, including the
inhibition of proteolytic activity of this venom, the inhib-
ition of procoagulant activity upon a solution of
Figure 2 Total antioxidant capacity of crude extract (CE) and
residual aqueous fraction (RA) from Jatropha gossypiifolia. The
results are expressed as milligram of ascorbic acid equivalents per
gram of sample (AAE). Values expressed as mean ± SEM with n = 3.
Félix-Silva et al. BMC Complementary and Alternative Medicine 2014, 14:405 Page 8 of 13
http://www.biomedcentral.com/1472-6882/14/405crude fibrinogen (which is attributed to serine prote-
ases thrombin-like from snake venom) and in vivo
inhibition of the hemorrhagic activity (which is at-
tributed to hemorrhagic metaloproteases from snake
venom), showing so that this extract has the ability
to inhibit snake venom proteases.
Having in mind the potentiality of CE and, mainly the
RA active fraction, as well as considering that the anti-
coagulant activity associated with antioxidant properties
could be beneficial for various cardiovascular diseases,
the antioxidant of CE and the RA active fraction were
also investigated.
Phenolic compounds are commonly found in both ed-
ible and non edible plants, and they have been reported
to have multiple biological effects, including antioxidant
activity. Extracts rich in phenolics are increasingly of
interest to the pharmaceutical and food industry [9]. As
discussed before in this paper, we could observe in both
CE and RA a great presence of these compounds, which
was another factor that prompted us to test the antioxi-
dant activity of these products.
The term “antioxidant” refers to compounds that can
prevent the formation of biological substances and chem-
ical oxidation damage induced by reactive species, such as
ROS. The formation process of these reactive species
occurs through a chain reaction involving three steps
(initiation, propagation and termination) wherein the
antioxidants act through several mechanisms. Thus, diffe-
rent methods were used to evaluate the effect of CE and
RA fraction at the different stages of initiation (e.g. total
antioxidant capacity and reducing power), propagation (e.
g. chelation of copper and iron ions) and termination (e.g.
scavenging of superoxide and hydroxyl radicals) [43].
The total antioxidant capacity test evaluates the ability
of a sample to donate electrons, thus neutralizing free
radicals such as ROS. As can be observed in Figure 2,
both CE and RA fraction presented significant antioxi-
dant activity in this test. The RA fraction, however, pre-
sented an antioxidant activity significantly (p < 0.05)
lower than CE, at about 18%. The values obtained by
both CE and RA was higher than the values obtained in
the same experiment with the plant Plukenetia volubilis,
which presented values ranging from 59.31 to 97.76 mg/
g of AAE, according to the extractor solvent used for ex-
tract preparation [8]. Thus, the detected values obtained
in the present study were extremely interesting, which
prompted us to conduct further antioxidant tests to de-
termine the potential antioxidant mechanisms of the J.
gossypiifolia CE and RA fraction.
The reducing power test evaluates the capacity of a
sample to donate electrons. The result of this test was
expressed in reducing activity equivalent to ascorbic acid
at a concentration of 0.2 μg/μL. It was observed that both
CE and RA presented highly significant reducing power, ascan be visualized in Figure 3. The activity obtained was very
similar for CE and RA (p > 0.05). As can be observed in the
Figure 3, at 1 and 0.5 μg/μL, CE and RA, respectively, pre-
sented reducing power higher than the ascorbic acid at
0.2 μg/μL (reducing activity in equivalents of 0.2 μg/μL as-
corbic acid higher than 100%), demonstrating a promising
result for antioxidant activity. The reducing power of com-
pounds seems to function as an inhibitor of chain reac-
tions of free radicals by means of donation of electrons,
since this activity is mediated by redox reactions [43].
The equilibrium of the concentration of copper ions in
biological systems is crucial for the regulation of cellular
functions. When an increase in its concentration occurs,
there is an increase in the production of reactive oxygen
species, due in large part to Fenton and Haber-Weiss reac-
tions. In addition, through the Fenton reaction, the pre-
formed lipid hydroperoxides are decomposed to form
alkoxyl radicals, strong oxidizing agents which can propa-
gate the chain reaction of lipid peroxidation or react with
other cellular constituents. Consequently, the chelation of
Figure 3 Reducing power of crude extract (CE) and residual aqueous fraction (RA) from Jatropha gossypiifolia. The results are expressed
as percentage of reducing activity equivalent to ascorbic acid in a concentration of 0.2 μg/μL. Values expressed as mean ± SEM with n = 3.
Figure 4 Copper chelating activity of crude extract (CE) and
residual aqueous fraction (RA) from Jatropha gossypiifolia. The
results are expressed as percentage of copper chelation. Values
expressed as mean ± SEM with n = 3.
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duction of reactive species that damage the target biomole-
cules [44,45]. Therefore, the copper ions chelating effect of
CE and RA fraction from J. gossypiifolia was evaluated. As
can be observed in Figure 4, both CE and RA fraction pre-
sented significant copper chelating activity, reaching up to
about 70% of copper chelation. Although the results were
very similar in CE and RA fraction, statistic significance
was observed for 0.1, 0.25 and 1 μg/μL concentrations
(p < 0.05), being the RA fraction slightly better than CE.
The iron chelating effect is very important since it in-
hibits the interaction between lipids and metals by forming
insoluble metal complexes with ferrous ions. Furthermore,
it is an effective way to eliminate the generation of hy-
droxyl radicals since it prevents iron from interacting with
hydrogen peroxide, thus preventing the decomposition of
hydrogen peroxide and the formation of an even more
damaging free radical [43]. As can be observed in Figure 5,
CE and RA fraction presented significant iron chelating
activity, reaching up to about 80% of chelation. Although
in smaller concentrations the activity shown by CE and
RA fraction was very similar, at 2 μg/μL RA fraction was
significantly more active, RA being about 12% more active
than CE (p < 0.001).
Hydroxyl radicals and superoxide anions are ROS im-
plicated in cell damage. The hydroxyl radical is the most
reactive of the radicals, making it extremely harmful. Its
main source of production in vivo is due to the reaction
of transition metals with the superoxide ion by the Fenton
reaction. On the other hand, superoxide anion is con-
sidered a primary ROS, capable of generating reactive
derivatives by direct interaction with other molecules or bymeans of processes catalyzed by metals or enzymes also
being produced within the mitochondria. Due to the
harmful effect on the body, these ROS are associated with
numerous diseases, such as strokes, cancer, diabetes, liver,
and neuronal lesions [6,7,46]. In view of this, the radical
scavenging activity of CE and RA fraction from J. gossypii-
folia was evaluated. As can be observed in Figures 6 and 7,
both CE and RA fraction presented significant radical
scavenging ability. In relation to hydroxyl radicals, al-
though no inhibition was observed in lower concentrations
(up to 0.5 μg/μL), at the higher concentrations, CE and
RA presented very high scavenging ability. CE was able to
Figure 5 Iron chelating activity of crude extract (CE) and residual aqueous fraction (RA) from Jatropha gossypiifolia. The results are
expressed as percentage of iron chelation. Values expressed as mean ± SEM with n = 3.
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was higher than that observed in RA fraction (p <
0.001), which achieved at most about 75% of scaven-
ging ability of hydroxyl radicals. On the other hand,
in the superoxide radical scavenging activity assay,
from the lowest concentrations, both CE and RA
showed high scavenging ability, and RA fraction was
more active than CE (p < 0.001).Figure 6 Hydroxyl radical scavenging activity of crude extract (CE) an
The results are expressed as percentage of scavenging of hydroxyl radicalsTable 3 summarizes the results obtained in the antioxi-
dant activity tests, showing the IC50 values for CE and RA
fraction. In general, RA fraction was more active (lower
IC50 value) than CE, with the exception of the hydroxyl
radical scavenging ability, as already discussed. The lower
IC50 for RA in superoxide radical scavenging ability
(about 5 times lower than CE) strongly suggests that this
fraction contains the main compounds responsible for thed residual aqueous fraction (RA) from Jatropha gossypiifolia.
. Values expressed as mean ± SEM with n = 3.
Figure 7 Superoxide radicals scavenging activity of crude
extract (CE) and residual aqueous fraction (RA) from Jatropha
gossypiifolia. The results are expressed as percentage of scavenging
of superoxide radicals. Values expressed as mean ± SEM with n = 3.
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gossypiifolia.
The antioxidant activity of extracts from J. gossypiifolia
was also evaluated earlier by Kharat et al. [47]. In this
work, firstly, the high content of phenols, tannins and fla-
vonoids in the leaves prompted the authors to evaluate the
antioxidant activity of the leaves. DPPH free radical, ferric
thiocyanate and nitric oxide scavenging methods were
used to analyze the in vitro antioxidant activity of metha-
nol, ethyl acetate and aqueous extracts, demonstrating
positive results. The authors attributed the free radical
scavenging activity to the presence of flavonoids [47]. On
the other hand, a study showed that different extracts
(petrol ether, chloroform, ethyl acetate and n-butanol)
from whole plant of J. gossypiifolia had only partial antioxi-
dant activity in DPPH scavenging, total antioxidant cap-
acity and lipid peroxidation tests [48]. From these extracts,
the ethyl acetate was the most active, which correlated
positively with its higher content of phenolic compounds
in comparison with the other extracts [48].
Considering that Jatropha species are known to be
toxic and considering previous studies that showed thatTable 3 IC50 of crude extract (CE) and residual aqueous




Copper chelation 0.111 0.081 0.017 (EDTA)
Iron chelation 1.104 1.034 0.011 (EDTA)
Hydroxyl radical scavenging 1.205 1.673 0.293 (gallic acid)
Superoxide radical scavenging 0.118 0.025 0.003 (gallic acid)
IC50: concentration that presents 50% of the referred activity.ethanol extracts from J. gossypiifolia aerial parts exhi-
bited noticeable toxicity [12,49], in vitro cytotoxicity
studies were performed as a preliminary method to evalu-
ate the potential toxicity of CE and the active fraction RA.
The potential hemolytic activity of CE and RA was in-
vestigated by measuring the lysis of a 20% (v/v) human
red blood cell (RBC) suspension in a spectrophotometric
lysis assay. CE and RA were tested at different concen-
trations (up to 2 μg/μL) and no significant red blood cell
lysis was observed (results not shown). Red blood cells
hemolysis is characterized by the breakdown of the red
blood cell membrane leading to the release of hemoglobin
into the surrounding plasma. This deleterious event can be
caused by a large number of conditions and can lead to
anemia and hypoxia. The osmotic fragility of the red blood
cell is classically used as an in vitro assay to evaluate the ef-
fects of chemicals on cell membrane [35,50].
The in vitro cytotoxicity of CE and RA was evaluated
in cell culture against human kidney epithelial cell line
(HEK-293 cells) by MTT assay, which measures indir-
ectly the cellular viability by quantification of the
amount of blue formazan crystals, which are the product
from the cleavage of MTT by cells presenting active
mitochondria [36]. The results showed that at any con-
centration tested (up to 1 μg/μL) CE and RA were not
cytotoxic, with a viability percentage similar to the con-
trol cells (treated only with medium in absence of sam-
ple) (results not shown).
The results suggest that even with the concentration of
the bioactive compounds in the RA fraction, there was no
increase in the toxicity of this fraction in relation to CE. It
is important to note that both RBC and HEK-293 are hu-
man cells, which can reinforce the absence of cytotoxicity
by CE and RA. These results suggest that the aqueous ex-
tract of the leaves, compared to the ethanol extract of the
aerial parts tested by Mariz et al. [51] may be less toxic
possibly due to an eventual difference in chemical compos-
ition that may have occurred, taking into account both the
different plant parts and extractor solvent used for the dif-
ferent preparation of the extracts. In fact, a study investi-
gating the acute oral toxicity of an aqueous leaf extract of
J. gossypiifolia showed no sign of toxicity in rats in doses
up to 2,000 mg/kg [52].
In conclusion, the presented results showed that J. gossy-
piifolia leaves, especially RA fraction, have significant bene-
ficial effects as an anticoagulant and antioxidant agent. In
addition, the absence of in vitro cytotoxicity against human
cells could reinforce its therapeutic potential. Thus, this
study shows the potential of this plant as a new source of
bioactive molecules for therapeutic purposes.
Conclusions
The results shown in this work demonstrate that the
aqueous leaf extract of the vegetal species Jatropha
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http://www.biomedcentral.com/1472-6882/14/405gossypiifolia has significant anticoagulant activity. Using a
bioguided fractionation assay, it was possible to conclude
that the fraction responsible for the activity in the crude
extract was the residual aqueous fraction. In addition to
the anticoagulant activity, this fraction also proved to be a
good source of antioxidant compounds. Since compounds
with anticoagulant and antioxidant can be used in current
medicine for treatment of various cardiovascular diseases,
we suggest that based in our results, the aqueous leaf
extract of J. gossypiifolia, specially its residual aqueous
fraction, shows promising potential as a future therapeutic
agent. In addition, the absence of in vitro cytotoxicity
against human cells could reinforce its potential. Thus, the
results presented here could give scientific evidence, at
least partially, for the popular use of this plant in com-
plementary and alternative medicine and show its potential
as a new source of bioactive molecules for therapeutic
purposes.
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